new year often means new prices for pharmaceuticals, and several companies have imposed price hikes just shy of 10 percent on numerous drugs, a move that appears designed to avoid withering scrutiny of companies that take double-digit increases.

One notable example is Allergan, which last year attempted to single-handedly staunch criticism of the pharmaceutical industry by issuing a “social contract” in which it promised to avoid “price gouging” and limit price hikes to single-digit percentage increases.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • May I observe under ‘the rule of 5’s,’ those increases count as 10 pct? Even the 9.5 percent one? Not that anyone will care of course…..

    • I would have much preferred 9.9999 percent. As any math student knows 9.9999 is a non-zero repeating infinitesimal that will never get to 10. Time for our critics to bone up on their irrationals.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.